Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 259 of 1,261
  1. US 11357817

    Immunoproteasome inhibitor

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  2. US 11357830

    Nano-scale delivery device and uses thereof

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  3. US 11357801

    Methods for treating autism spectrum disorder and associated symptoms

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  4. US 11357783

    Conjugate of finasteride with peptide

    CAREGEN CO., LTD. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  5. US 11357782

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  6. US 11357777

    Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)

    Cyclerion Therapeutics, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  7. US 11357736

    Detoxification using nanoparticles

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  8. US 11357743

    Ketamine and propofol admixture

    Regents of the University of Minnesota · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  9. US 11357770

    Method of treating immunoglobulin light chain amyloidosis

    Alterity Therapeutics Limited · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  10. US 11357727

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  11. US 11357725

    Delivery of agents using metastable liposomes

    LIPELLA PHARMACEUTICALS, INC. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  12. US 11357710

    Solid mask and preparation method therefor

    INFINITUS (CHINA) COMPANY LTD. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  13. US 11358953

    Functionalized peptides as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  14. US 11358932

    N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  15. US 11357860

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  16. US 11357841

    Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof

    Iovance Biotherapeutics, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  17. US 11357742

    Methods for treating cancer

    X4 Pharmaceuticals, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  18. US 11357759

    Composition including ADAM9 inhibitor and the use thereof

    China Medical University · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  19. US 11357795

    Combination immunotherapies for treatment of cancer

    PrimeVax Immuno-Oncology · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  20. US 11359024

    Anti-AVB8 antibodies and compositions and uses thereof

    The Regents of the University of California · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  21. US 11351197

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  22. US 11352607

    Genomic engineering of pluripotent cells

    Fate Therapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  23. US 11351198

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  24. US 11352360

    TGF-beta inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.